Breast cancer drug raises creatinine without necessarily signaling kidney damage, study finds
A routine blood test can make a kidney look like it is failing when it is not. A team from Kanazawa University and Shinshu University has shown that this happens often in patients with breast cancer who take abemaciclib, and that a simple baseline measurement can help doctors tell the difference.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Human skin models reveal how herpes spreads unevenly among neighboring cells
Science
Biology
Germany
-
Team publishes largest-ever dataset on real-world psychedelic support interactions
Science
Research
Global
-
Can creatine help your mental health? Here's what the latest evidence says
Health
Medicine
-
Post-COVID syndrome: Prednisolone shows modest, short-lived lift in treatment trial
Health
Medicine
-
How mental health and cancer survivorship intersect
Health
Mental Health
United States
-
New treatment reduces heart scarring and abnormal heart rhythms, offering a possibility for future therapies
Health
Medicine
United States
-
Why some patients quit a newer insomnia medication
Health
Medicine
-
Alcohol use held steady among cancer survivors
Health
Medicine
United States